GuideMedically reviewed Apr 2026

Mole on Eyelid: Cosmetic and Clinical Considerations

Eyelid moles sit in a delicate location with specific clinical considerations. The eyelid skin is among the thinnest on the body, the area is constantly moving, and any lesion is highly visible and potentially affecting vision. Most eyelid moles are benign nevi, but the eyelid is also a common location for basal cell carcinoma (BCC) and a less common but important site for melanoma and sebaceous carcinoma. This guide covers what's normal, what's concerning, and how eyelid lesion evaluation differs from elsewhere.

What's typical on eyelids

Common harmless eyelid lesions:

Intradermal nevus. Soft, dome-shaped, flesh-coloured or pale brown. Most common eyelid mole. Stable for years. Hair may grow through it normally.

Compound nevus. Slightly pigmented, can be flat or raised. Typically appears in adolescence or young adulthood and stays stable.

Milia. Tiny white pearly cysts, usually around the eyes. Trapped keratin. Benign.

Xanthelasma. Soft yellow-orange plaques, usually on inner upper eyelids, often associated with elevated cholesterol but not a cancer concern.

Syringoma. Small flesh-coloured papules under the eyes. Sweat-gland origin, benign.

Seborrheic keratosis. Waxy 'stuck-on' brown growth, common in older adults.

Papilloma. Pedunculated skin tag-like growth, benign.

For most eyelid moles, the diagnostic question is 'has it changed?' Stable lesions present for years are almost always benign.

Eyelid cancers — what to watch for

Basal cell carcinoma (BCC). The most common eyelid cancer, accounting for 80-90% of eyelid malignancies. Typical presentation: a pearly pink papule on the lower eyelid (most common location), often near the lash line, with telangiectasia (visible small blood vessels) and a central ulcerated area that bleeds and scabs. Slow-growing but locally destructive — can extend into the orbit if untreated.

Squamous cell carcinoma (SCC). Less common than BCC. Red or scaly nodule, may ulcerate. Can spread to lymph nodes if not treated.

Sebaceous carcinoma. Important to know about because it commonly mimics chalazion (cyst of the meibomian gland) for months before diagnosis. Yellowish nodule, usually on the upper eyelid. More aggressive than BCC. If a 'chalazion' has not resolved with normal treatment in 6-8 weeks, biopsy is warranted.

Melanoma. Rare on eyelid (about 1% of eyelid cancers). Pigmented lesion with irregular features, growth, or change. Can be cutaneous (on eyelid skin) or conjunctival (on the inner eyelid surface).

Merkel cell carcinoma. Rare but aggressive. Firm pink-red nodule, fast-growing.

Why eyelid lesions need careful evaluation

Eyelid skin is uniquely thin (some of the thinnest skin on the body), so lesions invade the underlying tissue more quickly than on thicker skin areas.

Proximity to the eye and lacrimal system means tumours can affect tear drainage, eyelid function, and vision if neglected.

Cosmetic and functional reconstruction after eyelid cancer surgery is more complex than on most skin sites. Earlier diagnosis means smaller excisions and better functional results.

Mohs micrographic surgery is the standard for most eyelid skin cancers. It removes the cancer in thin layers, examined microscopically until clear margins are achieved, preserving as much normal tissue as possible. Reconstruction is by oculoplastic surgery.

The practical implication: eyelid lesions deserve prompt evaluation when concerning, and the threshold for biopsy or referral to ophthalmology / oculoplastics is appropriately low.

Features that should prompt evaluation

Within 2-4 weeks if any:

New eyelid lesion that has appeared in the past 6 months.

Growing eyelid lesion (any size change over months).

Pearly pink papule on the lower eyelid lid margin.

Non-healing scab or ulcer on the eyelid.

Loss of eyelashes around an eyelid lesion (madarosis is a BCC sign).

Distortion of eyelid contour or function.

'Chalazion' that has not resolved in 6-8 weeks (sebaceous carcinoma masquerade).

Pigmented lesion with irregular borders, multiple colours, or asymmetry.

Within 1-2 weeks if any:

Rapidly growing eyelid lesion.

Bleeding from an eyelid lesion.

Vision affected by the lesion.

Personal history of eyelid or facial skin cancer.

Removal of benign eyelid moles

Cosmetic removal of clearly benign eyelid moles is straightforward but should be done by a dermatologist with eyelid experience or, ideally, an oculoplastic surgeon.

Shave excision under local anaesthetic. Suitable for raised soft moles. Takes 10-15 minutes. Healing 1-2 weeks.

Full-thickness excision for moles near the lash line or on the lid margin. May require small skin grafting in some cases.

Laser ablation. Less common; risk of unintended thermal damage to eyelid structures.

For any eyelid lesion being removed, send to pathology even if appearance is clearly benign. Hidden BCCs and melanomas are caught this way. The cost is small; the diagnostic value is significant.

Before removal, confirm:

The surgeon has eyelid experience.

The plan for reconstruction is appropriate (most simple shave excisions don't need reconstruction; full-thickness excisions may).

Recovery time matches your needs (most return to normal activity in 1-2 weeks).

When to see ophthalmology vs dermatology vs oculoplastic

Dermatology is appropriate for:

Most benign eyelid moles for monitoring or simple cosmetic removal.

Clearly suspicious cutaneous lesions that need biopsy.

General skin cancer surveillance.

Ophthalmology / oculoplastics is appropriate for:

Lid margin lesions that may need full-thickness excision.

Suspected sebaceous carcinoma or other rare eyelid cancers.

Lesions affecting vision or eyelid function.

Reconstructive needs after eyelid cancer surgery.

For most patients, starting with a dermatologist for evaluation is reasonable. The dermatologist refers to oculoplastics if the lesion warrants it. If you have direct access to oculoplastics or already see one, going there directly is also fine.

For any new, growing, or non-healing eyelid lesion, see a dermatologist or ophthalmologist within 2-4 weeks. Use our free ABCDE checker for the basics, but eyelid lesions warrant earlier specialist evaluation than similar lesions on other skin.

Start free ABCDE check

Sources

Content based on clinical guidelines from the American Academy of Dermatology (AAD), British Association of Dermatologists (BAD), and peer-reviewed literature from JAAD, BJD, and JAMA Dermatology. Epidemiological data from NCI SEER and IARC GLOBOCAN. Full methodology